Study Evaluating The SBI-087 In Subjects With Systemic Lupus Erythematosus

NCT00714116 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Lupus Erythematosus, Systemic

Interventions

DRUG: SBI-087

Sponsor

Pfizer

Collaborators

[object Object]